Ironwood Pharmaceuticals: CFO Resignation Knocks Shares - A Downgrade Is Due
Ironwood Pharmaceuticals Q1 Earnings Call Highlights
Ironwood Stock Down Despite Q1 Earnings and Revenue Beat
Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2026 Earnings Call Transcript
Ironwood Pharmaceuticals (IRWD) Tops Q1 Earnings and Revenue Estimates
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS)
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Best 5 Small-Cap Stocks With Forward EPS Growth Above 125%
IRWD Stock Down 14% in a Month: Time to Buy, Sell or Hold the Stock?
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
Insider Selling: Ironwood Pharmaceuticals (NASDAQ:IRWD) Director Sells $20,528,940.00 in Stock
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?
Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4?
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Ironwood Pharmaceuticals: Downgrading On Pipeline Setback And Extended Timeline For Apraglutide
IRWD Q4 Earnings and Revenues Fall Shy of Estimates, Stock Tanks
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2025 Earnings Call Transcript
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
What's in Store for These 5 Medical Companies This Earnings Season?
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.6% – Here’s What Happened
Ironwood vs. Bausch Health: Which GI Drug Stock is a Better Pick Now?
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
IRWD Rises 307% in 6 Months: Is This an Indication to Buy the Stock?
Ironwood Pharmaceuticals (NASDAQ:IRWD) & CytoDyn (OTCMKTS:CYDY) Critical Survey
3 Stocks Trading Near $5 With Massive Earnings Upside
Does Ironwood's Bullish 2026 View Signal Greater Linzess Adoption?
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Passes Above 200 Day Moving Average – Time to Sell?
4 Stocks Trading Near 52-Week High With More Upside Potential
Ironwood Pharmaceuticals' 2026 Guidance Shock Sparks a Major Re-Rating
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026
Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus
Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month High After Analyst Upgrade
Ironwood Pharma (IRWD) Surges on Strong FY26 Guidance and Pipeline Updates
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
Why Is Ironwood (IRWD) Up 24.9% Since Last Earnings Report?
Ironwood Pharmaceuticals (NASDAQ:IRWD) versus Citius Pharmaceuticals (NASDAQ:CTXR) Critical Analysis
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of “Hold” by Brokerages
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
Connor Clark & Lunn Investment Management Ltd. Grows Position in Ironwood Pharmaceuticals, Inc. $IRWD
Acadian Asset Management LLC Buys 3,904,498 Shares of Ironwood Pharmaceuticals, Inc. $IRWD
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
Google's AI chip 'Ironwood' takes on Nvidia